Structural computational modeling of RNA aptamers

Methods

Volumn 103, Issue , 2016, Pages 175-179

  Xu, Xiaojun ^a   Dickey, David D ^b   Chen, Shi Jie ^a   Giangrande, Paloma H ^b  

^a Informatics Institute   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

A9 aptamer; A9g aptamer; NAALADase Assay; Prostate specific membrane antigen (PSMA); RNA aptamers; RNA secondary and tertiary structure; Structural algorithms; Vfold2D model; Vfold3D model

Indexed keywords

APTAMER; NUCLEOTIDE; PROSTATE SPECIFIC MEMBRANE ANTIGEN; RNA; GLUTAMATE CARBOXYPEPTIDASE II;

ARTICLE; COMPUTER MODEL; GENE DELETION; GENE INSERTION; GENE MUTATION; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RNA ANALYSIS; RNA FOLDING; RNA SEQUENCE; RNA STRUCTURE; STRUCTURE ANALYSIS; CHEMISTRY; COMPUTER SIMULATION; CONFORMATION; INVERTED REPEAT; MOLECULAR MODEL; SOFTWARE; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE;

APTAMERS, NUCLEOTIDE; COMPUTER SIMULATION; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; INVERTED REPEAT SEQUENCES; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; SELEX APTAMER TECHNIQUE; SOFTWARE;

EID: 84960172092     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2016.03.004     Document Type: Article

References (33)

1. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249(4968):505-510.
2. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346(6287):818-822.
3. Thiel K.W., Giangrande P.H. Therapeutic applications of DNA and RNA aptamers. Oligonucleotides 2009, 19(3):209-222.
4. Keefe A.D., Pai S., Ellington A. Aptamers as therapeutics. Nat. Rev. Drug Discov. 2010, 9(7):537-550.
5. Dassie J.P., Giangrande P.H. Current progress on aptamer-targeted oligonucleotide therapeutics. Ther. Delivery 2013, 4(12):1527-1546.
6. Kruspe S., et al. Aptamers as drug delivery vehicles. ChemMedChem 2014, 9(9):1998-2011.
7. Sun H., et al. Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol. Ther. Nucleic Acids 2014, 3:e182.
8. Rohloff J.C., et al. Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents. Mol. Ther. Nucleic Acids 2014, 3:e201.
9. Blind M., Blank M. Aptamer selection technology and recent advances. Mol. Ther. Nucleic Acids 2015, 4:e223.
10. Ozer A., Pagano J.M., Lis J.T. New technologies provide quantum changes in the scale, speed, and success of SELEX methods and aptamer characterization. Mol. Ther. Nucleic Acids 2014, 3:e183.
11. Zhou J., Rossi J.J. Cell-type-specific, aptamer-functionalized agents for targeted disease therapy. Mol. Ther. Nucleic Acids 2014, 3:e169.
12. Lupold S.E., et al. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 2002, 62(14):4029-4033.
13. Rockey W.M., et al. Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling. Nucleic Acid Ther. 2011, 21(5):299-314.
14. Dassie J.P., et al. Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen. Mol. Ther. 2014, 22(11):1910-1922.
15. Dickey D.D., et al. Method for confirming cytoplasmic delivery of RNA aptamers. Methods Mol. Biol. 2016, 1364:209-217.
16. McNamara J.O., et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 2006, 24(8):1005-1015.
17. Xu X., Zhao P., Chen S.J. Vfold: a web server for RNA structure and folding thermodynamics prediction. PLoS ONE 2014, 9(9):e107504.
18. Cao S., Chen S.J. Predicting RNA folding thermodynamics with a reduced chain representation model. RNA 2005, 11(12):1884-1897.
19. Cao S., Chen S.J. Predicting RNA pseudoknot folding thermodynamics. Nucleic Acids Res. 2006, 34(9):2634-2652.
20. Cao S., Chen S.J. Predicting structures and stabilities for H-type pseudoknots with interhelix loops. RNA 2009, 15(4):696-706.
21. Cao S., Chen S.J. Structure and stability of RNA/RNA kissing complex: with application to HIV dimerization initiation signal. RNA 2011, 17(12):2130-2143.
22. Cao S., Chen S.J. A domain-based model for predicting large and complex pseudoknotted structures. RNA Biol. 2012, 9(2):200-211.
23. Cao S., Chen S.J. Physics-based de novo prediction of RNA 3D structures. J. Phys. Chem. B 2011, 115(14):4216-4226.
24. Xu X., Chen S.J. A method to predict the 3D structure of an RNA scaffold. Methods Mol. Biol. 2015, 1316:1-11.
25. Huang S.Y., Zou X. MDockPP: a hierarchical approach for protein-protein docking and its application to CAPRI rounds 15-19. Proteins 2010, 78(15):3096-3103.
26. Huang S.Y., Zou X. An iterative knowledge-based scoring function for protein-protein recognition. Proteins 2008, 72(2):557-579.
27. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31(13):3406-3415.
28. Zuker M., Sankoff D. RNA secondary structures and their prediction. Bull. Math. Biol. 1984, 46(4):591-621.
29. Bellaousov S., et al. RNAstructure: web servers for RNA secondary structure prediction and analysis. Nucleic Acids Res. 2013, 41(Web Server issue):W471-W474.
30. Mathews D.H., et al. An updated recursive algorithm for RNA secondary structure prediction with improved thermodynamic parameters. Molecular Modeling of Nucleic Acids 1998, 246-257. N.B. Leontis, J. SantaLucia (Eds.).
31. Hofacker I.L. Vienna RNA secondary structure server. Nucleic Acids Res. 2003, 31(13):3429-3431.
32. Hofacker I.L., Fontana W., Stadler P.F., Bonhoeffer L.S., Tacker M., Schuster P. Fast folding and comparison of RNA secondary structures. Chem. Monthly 1994, 125(2):167-188.
33. Parisien M., Major F. The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data. Nature 2008, 452(7183):51-55.